- •Table of Contents
- •Copyright
- •Contributors
- •How to Use this Study Guide
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •4: Outcomes Research
- •Questions
- •Answers
- •5: Core Principles of Perioperative Care
- •Questions
- •Answers
- •Questions
- •Answers
- •7: Principles of Urologic Endoscopy
- •Questions
- •Answers
- •8: Percutaneous Approaches to the Upper Urinary Tract Collecting System
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •12: Infections of the Urinary Tract
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •15: Sexually Transmitted Diseases
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •20: Principles of Tissue Engineering
- •Questions
- •Answers
- •Questions
- •Answers
- •22: Male Reproductive Physiology
- •Questions
- •Answers
- •Questions
- •Answers
- •24: Male Infertility
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •28: Priapism
- •Questions
- •Answers
- •Questions
- •Answers
- •30: Surgery for Erectile Dysfunction
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •34: Neoplasms of the Testis
- •Questions
- •Answers
- •35: Surgery of Testicular Tumors
- •Questions
- •Answers
- •36: Laparoscopic and Robotic-Assisted Retroperitoneal Lymphadenectomy for Testicular Tumors
- •Questions
- •Answers
- •37: Tumors of the Penis
- •Questions
- •Answers
- •38: Tumors of the Urethra
- •Questions
- •Answers
- •39: Inguinal Node Dissection
- •Questions
- •Answers
- •40: Surgery of the Penis and Urethra
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •47: Renal Transplantation
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •50: Upper Urinary Tract Trauma
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •53: Strategies for Nonmedical Management of Upper Urinary Tract Calculi
- •Questions
- •Answers
- •54: Surgical Management for Upper Urinary Tract Calculi
- •Questions
- •Answers
- •55: Lower Urinary Tract Calculi
- •Questions
- •Answers
- •56: Benign Renal Tumors
- •Questions
- •Answers
- •57: Malignant Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •59: Retroperitoneal Tumors
- •Questions
- •Answers
- •60: Open Surgery of the Kidney
- •Questions
- •Answers
- •Questions
- •Answers
- •62: Nonsurgical Focal Therapy for Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •66: Surgery of the Adrenal Glands
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •71: Evaluation and Management of Women with Urinary Incontinence and Pelvic Prolapse
- •Questions
- •Answers
- •72: Evaluation and Management of Men with Urinary Incontinence
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •76: Overactive Bladder
- •Questions
- •Answers
- •77: Underactive Detrusor
- •Questions
- •Answers
- •78: Nocturia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •82: Retropubic Suspension Surgery for Incontinence in Women
- •Questions
- •Answers
- •83: Vaginal and Abdominal Reconstructive Surgery for Pelvic Organ Prolapse
- •Questions
- •Answers
- •Questions
- •Answers
- •85: Complications Related to the Use of Mesh and Their Repair
- •Questions
- •Answers
- •86: Injection Therapy for Urinary Incontinence
- •Questions
- •Answers
- •87: Additional Therapies for Storage and Emptying Failure
- •Questions
- •Answers
- •88: Aging and Geriatric Urology
- •Questions
- •Answers
- •89: Urinary Tract Fistulae
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •92: Tumors of the Bladder
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •95: Transurethral and Open Surgery for Bladder Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •99: Orthotopic Urinary Diversion
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Answers
- •Questions
- •Answers
- •108: Prostate Cancer Tumor Markers
- •Questions
- •Answers
- •Questions
- •110: Pathology of Prostatic Neoplasia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •114: Open Radical Prostatectomy
- •Questions
- •Answers
- •Questions
- •Answers
- •116: Radiation Therapy for Prostate Cancer
- •Questions
- •Answers
- •117: Focal Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •119: Management of Biomedical Recurrence Following Definitive Therapy for Prostate Cancer
- •Questions
- •Answers
- •120: Hormone Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •124: Perinatal Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •126: Pediatric Urogenital Imaging
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •133: Surgery of the Ureter in Children
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •137: Vesicoureteral Reflux
- •Questions
- •Answers
- •138: Bladder Anomalies in Children
- •Questions
- •Answers
- •139: Exstrophy-Epispadias Complex
- •Questions
- •Answers
- •140: Prune-Belly Syndrome
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •144: Management of Defecation Disorders
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •147: Hypospadias
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •152: Adolescent and Transitional Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •154: Pediatric Genitourinary Trauma
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
87
Additional Therapies for Storage and Emptying Failure
Timothy B. Boone; Julie N. Stewart
Questions
1.All of the following patients would be candidates for augmentation cystoplasty EXCEPT:
a.a patient with a neurogenic bladder and poor bladder compliance who has failed anticholinergic medications and intravesical injections of botulinum toxin.
b.a patient with a spinal cord injury and detrusor leak point pressures of greater than 40 cm H2O and subsequent vesicoureteral reflux.
c.a patient with refractory idiopathic detrusor overactivity.
d.a patient with significant urinary frequency and a bladder capacity of less than 100 mL.
e.a patient with rapidly progressing multiple sclerosis and bothersome neurogenic detrusor overactivity causing urinary leakage.
2.Of the following statements, which one is NOT a potential side effect of an ileocystoplasty?
a.Hyperchloremic metabolic acidosis
b.Bacterial colonization and increased risk of urinary tract infections
c.Osteopenia
d.Hypochloremic hyponatremic alkalosis
e.Vitamin B12 deficiency
3.All of the following statements are TRUE regarding stimulated myoplasty for sphincteric deficiency EXCEPT:
a.Muscle type conversion from fast-twitch to slow-twitch fibers through continuous electrical stimulation provides resting tone for urethral closure.
b.The sartorius muscle is used as a free microsurgical flap.
c.An autologous muscle transfer provides circumferential pressure on the urethra or bladder neck.
d.The gracilis muscle is often utilized.
e.Electrode leads are implanted in the muscle in a staged, second procedure.
4.Which of the following statements is FALSE regarding urethral compression devices in a male?
a.Urethral pressure should be released at least twice per day.
b.They should be removed while sleeping.
c.Pressure-related injuries may occur in patients with altered cognition.
d.The lowest pressure that relieves incontinence should be used.
e.Patients with pure sphincteric incontinence will obtain the best results.
5.The Credé maneuver for emptying the bladder is relatively contraindicated in patients:
a.with decreased outlet resistance.
b.who are obese.
c.with vesicoureteral reflux.
d.with high-pressure detrusor overactivity.
e.younger than the age of 2 years.
6.Incontinence-associated dermatitis (IAD) is associated with the following factors in the incontinent patient EXCEPT:
a.It may be caused by infrequent pad changes.
b.It is manifested by inflammation of the skin with redness and edema.
c.It may lead to malignant lesions of the skin.
d.It predominately occurs in skin folds.
e.It promotes candidiasis and bacterial infections.
7.All of the following statements are TRUE regarding bladder outlet closure EXCEPT:
a.Complete closure of the bladder neck is rarely necessary.
b.The main indication is urethral destruction after prolonged catheter drainage.
c.An obstructing sling or artificial urinary sphincter (AUS) is rarely feasible, if less than 1 cm of urethra exists.
d.Reflex sphincteric activity may result in disruption of the bladder neck closure.
e.The transvaginal approach has decreased the postoperative fistula rate.
8.Of the following statements, which one is FALSE regarding "trigger voiding" in spinal cord-injured patients?
a.Trigger voiding can be induced by digital rectal stimulation.
b.Reflex contractions can be generated by using somatic motor axons to innervate parasympathetic bladder ganglia cells.
c.Rhythmic suprapubic manual pressure is usually the most effective method for trigger voiding.
d.Trigger voiding induces a reflex decrease in outlet resistance in patients with detrusor-sphincter dyssynergia.
e.Trigger voiding can be induced by squeezing the clitoris
9.Common complications associated with a continent catheterizable channel include all of the following EXCEPT:
a.stomal stenosis.
b.perforation of the catheterizable channel.
c.incontinence from the stoma site.
d.difficulty passing a catheter through the stoma due to stricture.
e.stomal prolapse.
.Which of the following statements is FALSE?
a.Chronic indwelling urethral catheterization protects against poor bladder compliance and upper tract complications.
b.Chronic indwelling urethral catheterization compared with clean intermittent catheterization (CIC) is associated with a higher incidence of urolithiasis.
c.Asymptomatic bacteriuria is common in catheterized patients and does not usually require treatment.
d.Periodic upper and lower tract evaluation is important in all patients managed with chronic indwelling catheters.
e.There is still a role for anticholinergic medications in patients managing their bladders with a chronic indwelling catheter.
.Clean intermittent catheterization is relatively contraindicated in patients with:
a.a history of urethral stricture disease.
b.bacteriuria.
c.autonomic dysreflexia.
d.decreased bladder compliance.
e.a history of a bladder neck artificial urinary sphincter.
.All of the following statements are TRUE regarding catheterization EXCEPT: a. there is no known association with intermittent catheterization and
development of squamous cell carcinoma of the bladder.
b.gross hematuria in a patient with a chronic indwelling catheter is likely related to infection or inflammation and does not require a thorough hematuria workup.
c.urinary incontinence may worsen in patients with intrinsic sphincter deficiency who convert from an indwelling urethral to suprapubic catheter.
d.there is a lower incidence of epididymitis in men who have chronic suprapubic catheters compared with urethral catheters.
e.there is a low risk of developing squamous cell carcinoma of the bladder with chronic indwelling catheter use.
Answers
1.e. A patient with rapidly progressing multiple sclerosis and bothersome neurogenic detrusor overactivity causing urinary leakage. A patient with a progressive neurologic disease, such as multiple sclerosis, may not have the ability to perform CIC in the future and an alternative treatment plan should be considered. Noncompliance with CIC puts the patient at risk for lifethreatening spontaneous bladder perforation.
2.d. Hypochloremic hyponatremic alkalosis. All of the statements are potential side effects of an ileocystoplasty except hypochloremic hyponatremic alkalosis. This metabolic abnormality is associated with a gastrocystoplasty.
3.b. The sartorius muscle is used as a free microsurgical flap. The use of an autologous muscle transfer to form a neosphincter around the urethra has been reported in a few small clinical series. Case reports describe transposition of the gracilis muscle to the urethra or bladder neck by transection of the distal muscle at the tibial tuberosity with preservation of the proximal neurovascular pedicle. The gracilis muscle is wrapped around either the bladder neck or the bulbous urethra and attached to itself (bulbous urethra) or the back of the os pubis (bladder neck), ensuring circumferential pressure on the urethra with electrical stimulation of the myoplasty.
4.a. Urethral pressure should be released at least twice per day. These devices are primarily used to treat patients with pure sphincteric incontinence, most commonly postprostatectomy incontinence, because normal bladder capacity and storage pressures are a relative requirement. Compression
devices should be unclamped regularly at 3-to 4-hour intervals, because prolonged or excessive compression can cause pressure-related injury to the penis. In addition, these devices should not be worn during an erection or while sleeping. Pressure-related injuries may also be more prevalent in patients with impaired sensation or cognition; therefore, penile clamp usage in this population should be considered a relative contraindication. Although these devices manage sphincteric incontinence relatively well, they are rarely used today because they are inconvenient, and many minimally invasive options for male sphincteric incontinence now exist. These devices remain useful for patients who cannot undergo surgical therapy because of medical conditions, and for patients who have severe leakage during the early postprostatectomy period while surgical treatment is contraindicated.
5.c. With vesicoureteral reflux. The Credé maneuver (manual compression of the bladder) is most effective in patients with decreased bladder tone who can generate an intravesical pressure greater than 50 cm H2O and
have decreased bladder outlet resistance. The Credé maneuver requires good hand control, is easier in a thin individual than an obese one, and is more easily performed in a child than in an adult. Voiding by Credé is unphysiologic, because active opening of the bladder neck does not occur, and increases in outlet resistance by a reflex mechanism may actually occur. If complete emptying does not occur, treatment to decrease outlet resistance can be contemplated, or an alternative method to empty the bladder should be used. Vesicoureteral reflux is a relative contraindication to external compression and straining maneuvers, especially in patients capable of generating a high intravesical pressure.
6.c. It may lead to malignant lesions of the skin. Prolonged exposure of the skin to a wet environment may lead to supersaturation and disruption of the skin's protective barriers, thus promoting skin maceration, dermatitis, and possibly infection. Incontinence-associated dermatitis (IAD) can be defined as inflammation of the surface of the skin with redness, edema, and, in some cases, bullae containing clear exudate. IAD predominately occurs in skin folds and may promote candidiasis or bacterial skin infections. IAD has not been associated with premalignant or malignant lesions of the skin.
7.e. The transvaginal approach has decreased the postoperative fistula rate.
Complete closure of the bladder neck is rarely necessary, because a compressive bladder neck sling is more easily performed, is less morbid, and allows transurethral access if necessary. The main indication for bladder
outlet closure is urethral destruction secondary to prolonged catheter drainage in neurogenic bladder patients. A case series using "tight" autologous pubovaginal sling and lower urinary tract reconstruction for urethras destroyed by long-term Foley catheter use reported excellent results with minimal incontinence. The authors concluded that at least 1 cm of normal urethra was required for proper functioning of the sling. The risk of complications, specifically a vesicovaginal fistula, is relatively common and can be difficult to repair. It is important to remember that a bladder neck closure is much more difficult than a simple closure of the bladder wall. The bladder neck is usually hyperactive in patients with neurologic disease, and every voiding reflex includes active opening and closing of the bladder neck, which forcibly attempts to destroy the bladder neck closure. To reduce this risk, postoperative suppression of the voiding reflex using prolonged continuous catheter drainage (3 weeks) and liberal use of anticholinergics is imperative. In addition, to reduce the risk of fistula, the repair must be watertight from the beginning, and this requires a precise mucosal closure using a running suture and multiple additional layers of muscle to reinforce the strength of the repair.
8.d. Trigger voiding induces a reflex decrease in outlet resistance in patients with sphincter dyssynergia. In some types of spinal cord injury or bladder dysfunction characterized by detrusor hyperreflexia, manual pressure may sometimes be used to initiate a reflexive bladder contraction— sometimes called "trigger voiding." The most effective method of initiating a reflex contraction is thought to be rhythmic suprapubic manual pressure, typically seven or eight compressions every 3 seconds. This rhythmic pressure is thought to produce a summation effect on the tension receptors in the bladder wall, resulting in an afferent neural discharge that activates the bladder reflex arc. Trigger voiding can also sometimes be induced by pulling the skin or hair of the pubis, scrotum, or thigh; squeezing the clitoris; or digital rectal stimulation. Surgical procedures to reduce outlet resistance should be considered, if significant obstruction or sphincter dyssynergia are present. In an animal model using neural rerouting, a detrusor contraction without striated sphincter dyssynergia could be initiated by scratching the skin or by percutaneous electrical stimulation in the L7 dermatome. The pathway was found to be mediated by cholinergic transmission at both ganglionic and peripheral levels. The importance of this experimental model is that somatic motor axons were able to innervate parasympathetic bladder
ganglion cells and therefore transfer somatic reflex activity to the lower urinary tract.
9.b. Perforation of the catheterizable channel. These catheterizable channels are not free of complications, and long-term issues with catheterization, incontinence and stomal stenosis can occur. A large retrospective study by Leslie et al (2011)* analyzed the long-term outcomes of 169 pediatric patients who had either undergone a Mitrofanoff appendicovesicostomy or a transverse ileal, or Monti, tube. The authors report a 39% revision rate (8% stricture, 4% prolapse, 10% incontinence, and 17% stomal stenosis at skin level). Perforation of the
catheterizable channel has not been commonly reported as a complication.
.a. Chronic indwelling urethral catheterization protects against poor bladder compliance and upper tract complications. The exact etiology of upper tract deterioration in patients with long-term indwelling catheters is unclear because the bladder should be well drained by a catheter; however, it is likely related to chronic "occult" or subclinical detrusor overactivity in the face of sphincteric dyssynergy providing a functional obstruction. Regardless of the etiology, it is clinically heralded by the development of poor detrusor compliance demonstrated on urodynamic studies.
.c. Autonomic dysreflexia. CIC should be used cautiously in patients known to have autonomic dysreflexia because bladder filling and bladder overdistention can be triggers for autonomic dysreflexia.
.b. Gross hematuria in a patient with a chronic indwelling catheter is likely related to infection or inflammation and does not require a thorough hematuria workup. The long-term risk of carcinoma in the spinal cord injury patient with a chronic catheter has been estimated to be 8% to 10%. This association has not been identified in patients performing intermittent catheterization. The development of gross hematuria in patients with a chronic indwelling catheter should prompt further evaluation, including upper tract imaging, urine cytology, cystoscopy, and consideration of bladder biopsy.
Chapter review
1.Indications for augmentation cystoplasty include poor bladder compliance, reduced capacity, and significant overactivity.
2.Chronic metabolic acidosis and osteopenia have been reported in patients over the long term who have had bladder augments with either ileum or
colon.
3.Gastrocystoplasty is rarely used because of the development of bladder erosions, perforation, the hematuria dysuria syndrome, and adenocarcinoma in the gastric segment.
4.Bladder augmentation should only be considered in patients who have the capability for self intermittent catheterization.
5.In patients who use intermittent catheterization or in those with chronic indwelling catheters, the presence of asymptomatic bacteriuria does not require treatment. Continued prophylactic antibiotics are rarely indicated in this group as well.
6.Lapedes proposed that high intravesical pressures with bladder overdistention reduces bladder blood flow and makes the bladder susceptible to bacterial invasion and significant urinary tract infections.
7.CIC should be used cautiously in patients known to have autonomic dysreflexia.
8.The frequency of intermittent catheterization should be such that bladder volumes remain below 400 to 500 mL between catheterizations.
9.The advantage of a suprapubic cystostomy in males compared with continuous urethral catheterization is a lower incidence of epididymitis and urethral stricture disease, with preservation of sexual function.
10.When bladder neck incision is performed, it should occur at the 5-and 7- o'clock position and extend caudally just proximal to the verumontanum. This results in retrograde ejaculation approximately 30% to 50% of the time.
11.Sphincterotomy should be performed at the 12-o'clock position because this is the position least likely to cause significant hemorrhage.
12.Compression devices should be unclamped regularly at 3-to 4-hour intervals, because prolonged or excessive compression can cause pressure-related injury to the penis.
13.The Credé maneuver (manual compression of the bladder) is most effective in patients with decreased bladder tone who can generate an intravesical pressure greater than 50 cm H2O and have decreased bladder
outlet resistance. Vesicoureteral reflux is a relative contraindication to external compression.
14.Bladder neck closure is much more difficult than a simple closure of the bladder wall. The bladder neck is usually hyperactive in patients with neurologic disease, and every voiding reflex includes active opening and
closing of the bladder neck, which forcibly attempts to destroy the bladder neck closure.
15.Catheterizable channels are not free of complications, and long-term issues with catheterization, incontinence and stomal stenosis can occur. There is a 39% revision rate (8% stricture, 4% prolapse, 10% incontinence, and 17% stomal stenosis at skin level).
16.The long-term risk of carcinoma in the spinal cord injury patient with a chronic catheter has been estimated to be 8% to 10%.
* Sources referenced can be found in Campbell-Walsh Urology, 11th Edition, on the Expert Consult website.